|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Matinas BioPharma Hldgs (AMEX: MTNB) through any online brokerage.
There are no as such competitors for Matinas BioPharma Hldgs.
The latest price target for Matinas BioPharma Hldgs (AMEX: MTNB) was reported by Aegis Capital on August 13, 2020. The analyst firm set a price target for 3.50 expecting MTNB to rise to within 12 months (a possible 221.10% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $1.09 last updated Mon Oct 25 2021 19:59:52 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the AMEX.